February 2021 Issue Table Of Contents

From The Editor

• When A Pandemic Provides You Lemons

Feature Articles

• Two Immigrants, One Unique Plan For A Biopharma

Capitol Perspectives

• Most Favored Nation Pricing Temporarily Halted By Courts

CEO Corner

• How Small Patient Advocacy Groups Can Help Advance Drug Development
• Bringing Global Business Perspectives To An Entrepreneurial Startup

Companies To Watch

• Akero Therapeutics

From Policy to Execution

• New Beginnings: Not Letting A Crisis Go To Waste

Industry Research

• Number Of EDC Systems Used — Current And Projected

Inside The Industry

• My Journey From Skepticism To Conviction Regarding AI
• Thrust Into A New Fundraising Norm
• Are You Ready For The Chief Medical Officer Role At A Biotech?
• RNA’s Rousing New Adventure
• From Medical Researcher To CEO
• I Picked A Heck Of A Time …
• COVID-19’s Impact On Outsourced Manufacturing
• CEO Q&A: Mary Szela

Leadership Lessons

• How To Help Your Team Contribute Ideas You Can Use

Ask The Board

• What Was The Biggest Challenge You Faced In The First Half Of 2020?
• Does It Seem Like Supplies (E.G., Lab Kits) For Ongoing Clinical Trials Have Been In Short Supply?
• How Important Is It To Bring Pharmaceutical Manufacturing Of American Drugs Back To America? Is This A Practical Issue Or A Political Issue?